Silo Pharma SILO Estimates

NASDAQ SILO
$1.53 -0.08 (-4.97%)
As of: Sep 30, 2026 · 3:22 PM EDT
Analyst Estimates

Silo Pharma, Inc. Quarterly Revenue Estimates

Periods 5
Next Period Q3 23
Consensus 17,377.83

Analysts expect Silo Pharma, Inc. to report revenue of 17,377.83 for Q3 23, against a range of 15,957.66 to 18,798.00. The most recent reported quarter, Q1 25, came in at 18,030.00.

Metric Q1 23Q2 23Q3 23Q4 23Q1 25
Reported (Actual) 18,000.0018,000.00--18,030.00
High Estimate -20,635.5518,798.0019,458.47-
Low Estimate -17,822.1715,957.6617,910.25-
Consensus Estimate -19,228.8617,377.8318,684.36-
Analyst Estimates

Silo Pharma, Inc. Quarterly Earnings Per Share (EPS) Estimates

Periods 5
Next Period Q3 23
Consensus -3.34

Analysts expect Silo Pharma, Inc. to report earnings per share of -3.34 for Q3 23, against a range of -3.57 to -3.11. The most recent reported quarter, Q1 25, came in at -3.45.

Metric Q1 23Q2 23Q3 23Q4 23Q1 25
Reported (Actual) -4.35-4.80---3.45
High Estimate --4.18-3.11-2.93-
Low Estimate --4.92-3.57-3.29-
Consensus Estimate --4.55-3.34-3.11-

Silo Pharma, Inc. Estimates API

Pull Wall Street consensus for Silo Pharma, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/estimates?ticker=SILO&mode=revenue&api_key=YOUR_API_KEY